Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare ... ( RICHMOND Calif. March 5 2013 /PRN...)

Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference

Date:3/5/2013

RICHMOND, Calif., March 5, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier , Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic^®development programs and an overview of the company's business strategy at 4:45 pm ET on Wednesday, March 13, 2013, at the Barclays Global Healthcare Conference which will be held in Miami.

(Logo: http://photos.prnewswire.com/prnh/20130102/SF35903LOGO)

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. The Company has ongoing Phase 2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic^® for the treatment of HIV/AIDS. Sangamo's other therapeutic programs are focused on monogenic diseases, including hemophilia, Huntington's disease and hemoglobinopathies such as beta-thalassemia and sickle cell anemia. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). Engineering of ZFPs that recognize a specific DNA sequence enables the creation of sequence-specific ZFP Nucleases (ZFNs) for gene modification and ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function. Sangamo has entered int
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Sangamo BioSciences Reports Second Quarter 2012 Financial Results
2. Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012
3. Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
4. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
5. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
7. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
8. Neurocrine Biosciences Reports First Quarter 2012 Results
9. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
10. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
11. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference

Post Your Comments:

(Date:5/21/2013)... Fla. , May 21, 2013 BioRestorative Therapies, ... life sciences company focused on developing stem cell based ... Mark Weinreb , its President and CEO, will ... The conference will be held on Thursday, May ... 109 E 42nd Street in New York City. Mr. ...

(Date:5/21/2013)... , May 21, 2013 STAAR Surgical Company ... and marketer of minimally invasive ophthalmic products, today announced ... to review the Company,s recent financial results and business ... Surgical will present at the 38 th Annual ... at the Westin Waterfront Hotel on Wednesday, ...

(Date:5/20/2013)... -- Volcano Corporation (NASDAQ: VOLC ) a leading ... to enhance the diagnosis and treatment of coronary and ... efforts to expand research and innovation surrounding its physiology ... ® (Instant Wave-Free Ratio™) 1 technologies, via ... 2013 in Paris . ...

Breaking Medicine Technology:BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2 BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3 STAAR Surgical To Present At Upcoming Investor Conferences 2 Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 2 Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 3 Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013 4

[0] BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference [0] STAAR Surgical To Present At Upcoming Investor Conferences [0] Volcano to Highlight its Physiology Expansion Efforts at EuroPCR 2013

... Precision and Reduce High Failure Rates in Central ... 16 ICON (Nasdaq: ICLR ) ... to the pharmaceutical, biotechnology and medical device industries ... patient evaluation, today announced that they have signed ...

... Patients on corticosteroids are one-third less likely to ... taking statin medicationsStudy is first in a series ... medicationsFRANKLIN LAKES, N.J., March 14 Results of ... Meeting of the American Academy of Asthma, Allergy ...

Cached Medicine Technology:ICON and MedAvante Sign Alliance Agreement 2 New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 2 New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 3 New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits 4

ICON and MedAvante Sign Alliance Agreement New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits

(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... to impossible, but a new study adds to a ... CT scans may help spot the beginnings of disease ... the greatest risk for lung cancer, 6 percent were ... and follow-up biopsies to confirm the diagnosis. CT scans ...

(Date:5/21/2013)... Sunnyvale, California (PRWEB) May 21, 2013 ... invites individuals who are grieving to remember and honor ... an Evening of Remembrance Memorial Service, Sunday, June 2, ... at Skyline Boulevard, San Mateo, CA 94402. , ... non-denominational, and includes a short program with music, readings ...

(Date:5/21/2013)... Calif. (PRWEB) May 21, 2013 Not ... a dual diagnosis of Borderline Personality Disorder (BPD) and ... is proving to be successful for the treatment of ... 1, Alina Gorgorian, Ph.D., clinical director of Clearview ... in Los Angeles, will provide attendees of the West ...

(Date:5/21/2013)... more likely than their normal-weight counterparts to repeatedly ... continuity of care and leads to more emergency ... The practice of "doctor shopping" among overweight patients ... the health care system, whether that be off-putting ... by providers, or improperly sized medical equipment and ...

(Date:5/21/2013)... N.C. An attack on glioblastoma brain tumor cells ... in an early study to establish the proper dose ... treatment, developed at Duke and tested in an ongoing ... cells have an abundance of receptors that work like ... the cells. , The investigational therapy, known as ...

Breaking Medicine News(10 mins):Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 2 Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 3 Health News:Hospice Offers Evening of Remembrance Memorial Service in San Mateo, California 2 Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 2 Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 3 Health News:'Doctor shopping' by obese patients negatively affects health 2 Health News:'Doctor shopping' by obese patients negatively affects health 3 Health News:Poliovirus vaccine trial shows early promise for recurrent glioblastoma 2

[0] Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer [0] Hospice Offers Evening of Remembrance Memorial Service in San Mateo, California [0] Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD [0] 'Doctor shopping' by obese patients negatively affects health [0] Poliovirus vaccine trial shows early promise for recurrent glioblastoma

... makers debate what levels of ozone in the air are ... that the inhaled pollutant impairs the bodys first line of ... as bacteria. , While it has long been known ... pollution, is associated with increased cardiovascular and pulmonary hospitalizations and ...

... Programs in ... Need, BUDAPEST, Hungary, Sept. 29 With more ... each year, it has never,been more critical to increase ... the U.S.-Middle East Partnership for,Breast Cancer Awareness and Research, ...

... finds 123 deaths linked to the products since 1969 ... experts on Friday urged the federal Food and Drug ... and cold medicines for young children. , The recommendation, ... in children under 2, and antihistamines in those younger ...

... MCLEAN, Va., Sept. 28 Sunrise Senior Living,Inc. ... on the status of the independent,investigation being conducted ... Directors, provided an update on management,s Sarbanes-Oxley,Section 404 ... on legal,proceedings. Special Independent Committee Investigation ...

... a,statement by ADA President Kathleen Roth, DDS, on ... Bill: "The American Dental Association applauds the ... in legislation reauthorizing,the State Children,s Health Insurance Program. ... care that they need to enjoy good,oral health. ...

... Medical today announced a,partnership with leading breast care ... including breast care physicians from,Connecticut to California, will ... and availability of an innovative, non-surgical,treatment option for ... will host a gathering of these new Centers ...

Ozone shuts down early immune response in lungs and body Susan G. Komen for the Cure Launches Unprecedented Global Expansion Program in 10 Countries FDA Advisers Urge Ban on Cold Medicines for Young Children Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Management's Internal Control Review Efforts and on Legal Proceedings Statement by ADA President Kathleen Roth, DDS, on the Inclusion of Stable Dental Benefit in SCHIP Reauthorization Bill Sanarus Announces Partnership With Leading US Breast Care Physicians for the Next Generation Visica 2(TM) Treatment System for Fibroadenomas

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

Medicine Products:

Allergen, Food, Chocolate IgG Allergen, Food, Clam Allergen, Food, Cherry Allergen, Food, Chili Pepper